130 related articles for article (PubMed ID: 10761329)
1. A case of a sclerosing stromal ovarian tumor that expresses VEGF.
Ishioka S; Sagae S; Saito T; Kiya T; Akutagawa N; Sugimura M; Kudo R
J Obstet Gynaecol Res; 2000 Feb; 26(1):35-8. PubMed ID: 10761329
[TBL] [Abstract][Full Text] [Related]
2. Sclerosing stromal tumor of the ovary: a clinicopathologic, immunohistochemical, ultrastructural, and cytogenetic analysis with special reference to its vasculature.
Kawauchi S; Tsuji T; Kaku T; Kamura T; Nakano H; Tsuneyoshi M
Am J Surg Pathol; 1998 Jan; 22(1):83-92. PubMed ID: 9422320
[TBL] [Abstract][Full Text] [Related]
3. Expression of angiogenic factors in sclerosing stromal tumours of the ovary.
Hirakawa T; Kawano Y; Mizoguchi C; Nasu K; Narahara H
J Obstet Gynaecol; 2018 Jul; 38(5):682-685. PubMed ID: 29433373
[TBL] [Abstract][Full Text] [Related]
4. RT in situ PCR for VEGF mRNA in sclerosing stromal tumor.
Kawauchi S; Fukuda T; Tsuneyoshi M
Am J Surg Pathol; 2000 Jan; 24(1):156-7. PubMed ID: 10632502
[No Abstract] [Full Text] [Related]
5. Clinicopathological and immunohistochemical analysis of sclerosing stromal tumours of the ovary.
Zekioglu O; Ozdemir N; Terek C; Ozsaran A; Dikmen Y
Arch Gynecol Obstet; 2010 Dec; 282(6):671-6. PubMed ID: 20135135
[TBL] [Abstract][Full Text] [Related]
6. Sclerosing stromal tumor of the ovary: a case report and review of the literature.
Stylianidou A; Varras M; Akrivis C; Fylaktidou A; Stefanaki S; Antoniou N
Eur J Gynaecol Oncol; 2001; 22(4):300-4. PubMed ID: 11695814
[TBL] [Abstract][Full Text] [Related]
7. Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma.
Boocock CA; Charnock-Jones DS; Sharkey AM; McLaren J; Barker PJ; Wright KA; Twentyman PR; Smith SK
J Natl Cancer Inst; 1995 Apr; 87(7):506-16. PubMed ID: 7707437
[TBL] [Abstract][Full Text] [Related]
8. [Expression of vascular endothelial growth factor and microvessel density in ovarian tumor].
Qi SY
Ai Zheng; 2003 Mar; 22(3):320-3. PubMed ID: 12654197
[TBL] [Abstract][Full Text] [Related]
9. Strong expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in ovarian borderline and malignant neoplasms.
Abu-Jawdeh GM; Faix JD; Niloff J; Tognazzi K; Manseau E; Dvorak HF; Brown LF
Lab Invest; 1996 Jun; 74(6):1105-15. PubMed ID: 8667614
[TBL] [Abstract][Full Text] [Related]
10. Sclerosing stromal tumor: an important differential diagnosis of ovarian neoplasms in childhood and adolescence.
Gwin K; Mariño-Enríquez A; Martel M; Reyes-Múgica M
Pediatr Dev Pathol; 2009; 12(5):366-70. PubMed ID: 19071970
[TBL] [Abstract][Full Text] [Related]
11. Association of vascular endothelial growth factor expression with tumor cell proliferation in ovarian carcinoma.
Mattern J; Stammler G; Koomagi R; Wallwiener D; Kaufmann M; Volm M
Anticancer Res; 1997; 17(1B):621-4. PubMed ID: 9066589
[TBL] [Abstract][Full Text] [Related]
12. Alterations in SPARC and VEGF immunoreactivity in epithelial ovarian cancer.
Paley PJ; Goff BA; Gown AM; Greer BE; Sage EH
Gynecol Oncol; 2000 Sep; 78(3 Pt 1):336-41. PubMed ID: 10985890
[TBL] [Abstract][Full Text] [Related]
13. Sclerosing stromal tumor of the ovary in a perimenopausal woman: a case report.
Liu SJ; Lv W; Shi M
Eur J Gynaecol Oncol; 2017; 38(2):326-328. PubMed ID: 29953807
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of microvessel density, vascular cuffing and vascular endothelial growth factor expression in ovarian carcinoma: a special review for clear cell adenocarcinoma.
Ogawa S; Kaku T; Kobayashi H; Hirakawa T; Ohishi Y; Kinukawa N; Nakano H
Cancer Lett; 2002 Feb; 176(1):111-8. PubMed ID: 11790460
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor (VEGF) expression in primary tumors and peritoneal metastases from patients with advanced ovarian carcinoma.
Gadducci A; Viacava P; Cosio S; Cecchetti D; Fanelli G; Fanucchi A; Teti G; Genazzani AR
Anticancer Res; 2003; 23(3C):3001-8. PubMed ID: 12926153
[TBL] [Abstract][Full Text] [Related]
16. Expression and localization of the vascular endothelial growth factor family in ovarian epithelial tumors.
Sowter HM; Corps AN; Evans AL; Clark DE; Charnock-Jones DS; Smith SK
Lab Invest; 1997 Dec; 77(6):607-14. PubMed ID: 9426398
[TBL] [Abstract][Full Text] [Related]
17. Sclerosing stromal tumor of the ovary in a 4-year-old girl with characteristics of an ovarian signet-ring stromal tumor.
He Y; Yang KX; Jiang W; Wang DQ; Li L
Pathol Res Pract; 2010 May; 206(5):338-41. PubMed ID: 19604650
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological Characteristics of Ovarian Sclerosing Stromal Tumor with an Emphasis on TFE3 Overexpression.
Park CK; Kim HS
Anticancer Res; 2017 Oct; 37(10):5441-5447. PubMed ID: 28982854
[TBL] [Abstract][Full Text] [Related]
19. Expression of endocrine gland-derived vascular endothelial growth factor in ovarian carcinoma.
Zhang L; Yang N; Conejo-Garcia JR; Katsaros D; Mohamed-Hadley A; Fracchioli S; Schlienger K; Toll A; Levine B; Rubin SC; Coukos G
Clin Cancer Res; 2003 Jan; 9(1):264-72. PubMed ID: 12538479
[TBL] [Abstract][Full Text] [Related]
20. Hyaline globules and progesterone receptors in an ovarian sclerosing stromal tumour.
Lifschitz-Mercer B; Open M; Kushnir I; Jacob N; Caspi B; Czernobilsky B
Histopathology; 1995 Aug; 27(2):195-7. PubMed ID: 8835271
[No Abstract] [Full Text] [Related]
[Next] [New Search]
